Standardizing clinical laboratory data for secondary use
- PMID: 22561944
- PMCID: PMC3419308
- DOI: 10.1016/j.jbi.2012.04.012
Standardizing clinical laboratory data for secondary use
Abstract
Clinical databases provide a rich source of data for answering clinical research questions. However, the variables recorded in clinical data systems are often identified by local, idiosyncratic, and sometimes redundant and/or ambiguous names (or codes) rather than unique, well-organized codes from standard code systems. This reality discourages research use of such databases, because researchers must invest considerable time in cleaning up the data before they can ask their first research question. Researchers at MIT developed MIMIC-II, a nearly complete collection of clinical data about intensive care patients. Because its data are drawn from existing clinical systems, it has many of the problems described above. In collaboration with the MIT researchers, we have begun a process of cleaning up the data and mapping the variable names and codes to LOINC codes. Our first step, which we describe here, was to map all of the laboratory test observations to LOINC codes. We were able to map 87% of the unique laboratory tests that cover 94% of the total number of laboratory tests results. Of the 13% of tests that we could not map, nearly 60% were due to test names whose real meaning could not be discerned and 29% represented tests that were not yet included in the LOINC table. These results suggest that LOINC codes cover most of laboratory tests used in critical care. We have delivered this work to the MIMIC-II researchers, who have included it in their standard MIMIC-II database release so that researchers who use this database in the future will not have to do this work.
Published by Elsevier Inc.
Figures


References
-
- Regenstrief Institute. [Accessed October 3, 2011];Logical Observation Identifiers Names and Codes. Web site. http://loinc.org/. Updated September 28, 2011.
-
- Mahon BE, Rosenman MB, Kleiman MB. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. J Pediatr. 2001 Sep;139(3):380–4. - PubMed
-
- Gliklich RE, Dreyer NA, editors. (Prepared by Outcome DEcIDE Center [Outcome Sciences, Inc. d/b/a Outcome] under Contract No. HHSA29020050035I TO3.) AHRQ Publication No.10-EHC049. 2. Rockville, MD: Agency for Healthcare Research and Quality; Sep, 2010. Registries for Evaluating Patient Outcomes: A User’s Guide.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources